Clinical Trials for Colorectal Cancer
GI004
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study. View Details.
GI008
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease. View details.